Fluoropolymer In Healthcare Global Market Report 2025

The fluoropolymers in the healthcare market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.9 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to the increased adoption of medical catheters, a rise in the use of minimally invasive surgical procedures, growing demand for biocompatible materials, greater preference for disposable medical equipment, and the rising prevalence of chronic diseases.

The fluoropolymers in the healthcare market size is expected to see strong growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth anticipated in the forecast period can be attributed to the rising demand for advanced drug delivery systems, increased use of fluoropolymer coatings in surgical instruments, growing investments in healthcare infrastructure, heightened awareness of infection control, and the expanding need for temperature-resistant materials. Key trends expected during this period include innovations in medical tubing design, advancements in biocompatible fluoropolymers, progress in additive manufacturing technologies, research into sustainable fluoropolymer materials, and the integration of smart fluoropolymer-based devices.

The rising demand for minimally invasive surgical devices is expected to drive the growth of fluoropolymers in the healthcare market. Minimally invasive surgical devices (MISDs) are advanced tools used to perform procedures through small incisions, aiming to reduce recovery time and minimize complications. This growing demand is fueled by the need for faster recovery, as MISDs cause less bodily trauma and lead to shorter hospital stays. Fluoropolymers play a crucial role in these devices due to their chemical resistance, low friction, and biocompatibility, which enhance device performance and ensure patient safety. Their durability enables precise and dependable surgical operations. For example, in January 2025, Intuitive Surgical, Inc., a U.S.-based medical device company, reported that its surgical products were used in nearly 2.7 million procedures in 2024, representing a 17% increase compared to 2023. Thus, the growing demand for minimally invasive surgical devices is contributing to the expansion of fluoropolymers in the healthcare market.

Leading companies in the fluoropolymers healthcare market are focusing on the development of advanced products, such as fluoropolymer-based fluidic systems, to improve precision and durability in medical devices and diagnostic applications. These systems utilize fluoropolymer materials to manage fluid flow accurately and safely in medical and laboratory environments. Their chemical resistance, low friction, and biocompatibility ensure reliable performance in critical healthcare uses. For example, in May 2023, Biotech Fluidics AB, a Sweden-based provider of fluidic and degassing solutions, introduced a new line of traceable, certified PEEK and fluoropolymer flexible tubing. This tubing is designed for use in regulated environments such as medical and life sciences and complies with stringent standards, including ISO 10993, US Pharmacopeia Class VI, FDA Title 21, and EU Regulation 1907/2006 (regarding DEHP content). Available in both bulk and pre-cut quantities with complete traceability, the tubing can also be delivered sterilized in cleanroom assemblies when required. It is engineered to meet rigorous international regulatory requirements, making it well-suited for critical applications where safety, biocompatibility, and traceability are essential.

In February 2024, EQT Private Equity, a Sweden-based investment firm, acquired Zeus for an undisclosed amount. Through this acquisition, EQT Private Equity intends to support Zeus’s expansion and innovation in advanced polymer solutions, with a focus on the medical and high-tech sectors. Zeus is a U.S.-based company specializing in the design, development, and extrusion of fluoropolymer tubing used in medical devices.

Major players in the fluoropolymer in healthcare market are Saint-Gobain S.A., Daikin Industries Ltd., 3M Company, Solvay S.A., AGC Inc., DuPont de Nemours Inc., Arkema S.A., Orbia, The Chemours Company, Datwyler, Kureha Corporation, Pexco, Gujarat Fluorochemicals Ltd., Specialty Coating Systems Inc., W.L. Gore & Associates, Duke Empirical, Halopolymer OJSC, Fluorotherm, Dalau Limited, Everflon Fluoropolymers.

North America was the largest region in the fluoropolymers in the healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fluoropolymers in the healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fluoropolymers in the healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Fluoropolymers are high-performance materials extensively used in healthcare due to their outstanding chemical resistance, biocompatibility, and ability to endure high temperatures. Their non-reactive and non-stick nature makes them highly suitable for medical devices, offering consistent performance and durability, even after repeated sterilization. Their inertness and strength also make them well-suited for fluid handling applications.

The primary types of fluoropolymers used in healthcare include polytetrafluoroethylene (PTFE), polyvinylidene difluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polyvinyl fluoride (PVF), and others. PTFE is a heat-resistant, low-friction, and chemically inert fluoropolymer valued in medical applications for its strength and biocompatibility. It is available in multiple forms such as films, coatings, wrappings, and tubings - and serves a range of uses including medical devices, pharmaceutical packaging, laboratory instruments, and protective apparel. These materials are utilized by end-users like hospitals and clinics, pharmaceutical companies, research laboratories, and contract manufacturing organizations (CMOs).

The fluoropolymer in healthcare market research report is one of a series of new reports that provides fluoropolymer in healthcare market statistics, including the fluoropolymer in healthcare industry global market size, regional shares, competitors with the fluoropolymer in healthcare market share, detailed fluoropolymer in healthcare market segments, market trends, opportunities, and any further data you may need to thrive in the fluoropolymer in healthcare industry. This fluoropolymer in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fluoropolymers in the healthcare market consist of sales of perfluoropolyether, perfluorocyclobutyl polymers, and fluoroethylene propylene rubber. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.